4//SEC Filing
Bruehlman Ronald E 4
Accession 0001809519-25-000002
CIK 0001809519other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:07 PM ET
Size
5.2 KB
Accession
0001809519-25-000002
Insider Transaction Report
Form 4
Bruehlman Ronald E
Director
Transactions
- Award
Class A Common Stock
2025-01-01+10,653→ 32,284 total
Footnotes (1)
- [F1]Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001604076
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 7:07 PM ET
- Size
- 5.2 KB